  Cancer-related cognitive impairment ( CRCI) is a widespread problem for the increasing population of cancer survivors. Our understanding of the nature , causes , and prevalence of CRCI is hampered by a reliance on clinical neuropsychological methods originally designed to detect focal lesions<symptom>. Future progress will require collaboration between neuroscience and clinical neuropsychology.